Abstract | BACKGROUND: AIMS: We investigated the association of plasma levels of soluble MMP-9 and TIMP-1 with clinical, laboratory and echocardiographic parameters and estimated their prognostic value in the prediction of all-cause death. METHODS: RESULTS: After adjustment for age, sex and creatinine, levels of TIMP-1 (1640 vs. 735 ng/ml, P<0.001) but not MMP-9 were elevated in CHF patients compared to controls. During a median follow-up period of 2.5 years, 66 patients (27%) died. In multivariable Cox regression models TIMP-1 but not MMP-9 emerged as an independent predictor of all-cause death (hazard ratio per tertile, 3.5; 95% confidence interval [CI], 2.2-5.1). In addition to the full set of univariately predictive clinical and serological markers, information on TIMP-1 significantly increased the area under the receiver operating characteristic curve from 0.77 (95% CI, 0.71-0.84) to 0.87 (95% CI, 0.82-0.92). CONCLUSION: In stable CHF patients, TIMP-1 but not MMP-9 is of independent and incremental value regarding the prediction of all-cause death.
|
Authors | S Frantz, S Störk, K Michels, M Eigenthaler, G Ertl, J Bauersachs, C E Angermann |
Journal | European journal of heart failure
(Eur J Heart Fail)
Vol. 10
Issue 4
Pg. 388-95
(Apr 2008)
ISSN: 1388-9842 [Print] England |
PMID | 18343723
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- Tissue Inhibitor of Metalloproteinase-1
- Tumor Necrosis Factor-alpha
- Matrix Metalloproteinase 9
|
Topics |
- Aged
- Biomarkers
(blood)
- Cardiac Output, Low
(blood, diagnosis, mortality)
- Cause of Death
- Echocardiography
- Female
- Heart Failure
(blood, diagnosis, mortality)
- Humans
- Male
- Matrix Metalloproteinase 9
(blood)
- Middle Aged
- Predictive Value of Tests
- Prognosis
- Proportional Hazards Models
- Prospective Studies
- Reference Values
- Tissue Inhibitor of Metalloproteinase-1
(blood)
- Tumor Necrosis Factor-alpha
(blood)
|